SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency
Inherited deficiency of the RNA lariat-debranching enzyme 1 (DBR1) is a rare etiology of brainstem viral encephalitis. The cellular basis of disease and the range of viral predisposition are unclear. We report inherited DBR1 deficiency in a 14-year-old boy who suffered from isolated SARS-CoV-2 brain...
Saved in:
Published in | The Journal of experimental medicine Vol. 221; no. 9 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Rockefeller University Press
2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Inherited deficiency of the RNA lariat-debranching enzyme 1 (DBR1) is a rare etiology of brainstem viral encephalitis. The cellular basis of disease and the range of viral predisposition are unclear. We report inherited DBR1 deficiency in a 14-year-old boy who suffered from isolated SARS-CoV-2 brainstem encephalitis. The patient is homozygous for a previously reported hypomorphic and pathogenic DBR1 variant (I120T). Consistently, DBR1 I120T/I120T fibroblasts from affected individuals from this and another unrelated kindred have similarly low levels of DBR1 protein and high levels of RNA lariats. DBR1 I120T/I120T human pluripotent stem cell (hPSC)-derived hindbrain neurons are highly susceptible to SARS-CoV-2 infection. Exogenous WT DBR1 expression in DBR1 I120T/I120T fibroblasts and hindbrain neurons rescued the RNA lariat accumulation phenotype. Moreover, expression of exogenous RNA lariats, mimicking DBR1 deficiency, increased the susceptibility of WT hindbrain neurons to SARS-CoV-2 infection. Inborn errors of DBR1 impair hindbrain neuron-intrinsic antiviral immunity, predisposing to viral infections of the brainstem, including that by SARS-CoV-2. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Report-3 ObjectType-Case Study-4 PMCID: PMC11256911 Disclosures: F. Pinci and O. Harschnitz reported a patent to differentiation of hindbrain neurons from human pluripotent stem cells pending. I. Meyts reported grants from CSL-Behring, FWO Vlaanderen G0B5120N, KU Leuven, and Jeffrey Modell Foundation during the conduct of the study; and “other” from Takeda and Boehringer-Ingelheim outside the submitted work. M.R Wilson reported grants from Genentech and Novartis, and personal fees from Delve Bio outside the submitted work. S. Berg reported personal fees from speaker’s bureau, SOBI outside the submitted work. No other disclosures were reported. D. Lee, F. Pinci, and S. Volpi contributed equally to this paper. Y.-H. Chan, V. Lundberg, J. Le Pen, and J. Yuan contributed equally to this paper. O. Harschnitz, C.M. Rice, L. Studer, J.-L. Casanova, O. Ekwall, and S.-Y. Zhang contributed equally to this paper. |
ISSN: | 0022-1007 1540-9538 1540-9538 |
DOI: | 10.1084/jem.20231725 |